As previously reported, BofA/Merrill Health to Neutral from Buy and lowered its price target to $135 from $150. Analyst Kevin Fischbeck said the Trump victory and Republican sweep of Congress is a negative for the entire Healthcare Facilities sector as Republicans want to repeal the Affordable Care Act and cut spending. The analyst said the trend is towards less coverage, which will impact volumes and increase bad debt in general.
Barclays analyst Andrew Mok raised the firm's price target on Universal Health to $189 from $181 and keeps an Equal Weight rating on the shares post the Q1 report. The company posted broad pricing strength and strong acute inpatient volumes, which drove a big EBITDA beat, the analyst tells investors in a research note.
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here